minoxidil has been researched along with Kaposi Sarcoma in 1 studies
Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pavlovitch, JH | 1 |
| Hubert, H | 1 |
| Leibovitch, J | 1 |
1 other study available for minoxidil and Kaposi Sarcoma
| Article | Year |
|---|---|
Angiogenesis and minoxidil.
Topics: Administration, Topical; Adult; HIV Seropositivity; Humans; Male; Minoxidil; Neovascularization, Pat | 1990 |